Paul E. Freiman - 21 May 2022 Form 4 Insider Report for NovaBay Pharmaceuticals, Inc. (NBY)

Role: Director
Signature: /s/ Justin Hall as attorney in fact for Paul E. Freiman
Issuer symbol: NBY
Transactions as of: 21 May 2022
Net transactions value: $0
Form type: 4
Filing time: 24 May 2022, 19:30:33 UTC
Previous filing: 13 May 2022
Next filing: 15 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NBY	Common Stock	Options Exercise		+30,000			30,000	21 May 2022	Direct	F1
holding	NBY	Common Stock						2,311	21 May 2022	Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NBY	Restricted Stock Units	Options Exercise	$0	-30,000	-50%	$0.000000	30,000	21 May 2022	Common Stock	30,000		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.